HJ timeline
Every HJ batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| HJ-2608-C7002 | Semaglutide | 23 Aug 2026 | 2026-Q3 | 12 | 99.21 | 0.90 | 99.33 | +0.12 | |
| HJ-2605-D6191 | Tirzepatide | 13 May 2026 | 2026-Q2 | 7 | 98.60 | 0.70 | 98.50 | -0.10 | |
| HJ-2604-T6645 | Ipamorelin | 04 Apr 2026 | 2026-Q2 | 6 | 98.69 | 0.58 | 99.31 | +0.62 | |
| HJ-2603-R5329 | GHRP-6 | 02 Mar 2026 | 2026-Q3 | 5 | 99.37 | 0.88 | 99.35 | -0.02 | |
| HJ-2602-W6219 | GHRP-2 | 18 Feb 2026 | 2026-Q2 | 3 | 99.05 | 0.61 | 99.55 | +0.50 | |
| HJ-2601-N5554 | AOD-9604 | 16 Jan 2026 | 2026-Q2 | 7 | 99.17 | 0.66 | 99.23 | +0.06 | |
| HJ-2601-H6673 | TB-500 | 12 Jan 2026 | 2026-Q1 | 3 | 99.65 | 0.30 | 99.59 | -0.06 | |
| HJ-2512-X6599 | GHRP-2 | 17 Dec 2025 | 2026-Q1 | 1 | 99.93 | n<2 | 100.00 | +0.07 | |
| HJ-2511-B6617 | Tirzepatide | 22 Nov 2025 | 2026-Q2 | 5 | 99.01 | 0.97 | 98.98 | -0.03 | |
| HJ-2511-P5900 | BPC-157 | 21 Nov 2025 | 2026-Q2 | 7 | 99.72 | 0.60 | 99.90 | +0.18 | |
| HJ-2511-D7081 | Ipamorelin | 19 Nov 2025 | 2025-Q4 | 6 | 99.02 | 0.83 | 99.43 | +0.41 | |
| HJ-2511-V5472 | TB-500 | 16 Nov 2025 | 2026-Q1 | 2 | 99.76 | 0.11 | 99.90 | +0.14 | |
| HJ-2511-U6485 | BPC-157 | 14 Nov 2025 | 2026-Q2 | 9 | 98.86 | 0.44 | 99.51 | +0.65 | |
| HJ-2511-L7241 | TB-500 | 14 Nov 2025 | 2026-Q2 | 1 | 99.41 | n<2 | 98.64 | -0.77 | |
| HJ-2511-F6153 | L-Glutathione (reduced) | 04 Nov 2025 | 2026-Q2 | 8 | 99.93 | 0.27 | 99.90 | -0.03 | |
| HJ-2508-P6487 | Tirzepatide | 30 Aug 2025 | 2026-Q1 | 10 | 98.55 | 1.36 | 98.60 | +0.05 | |
| HJ-2508-C7084 | ARA-290 | 22 Aug 2025 | 2026-Q1 | 13 | 99.21 | 0.66 | 99.90 | +0.69 | |
| HJ-2507-S5943 | PEG-MGF | 30 Jul 2025 | 2025-Q3 | 9 | 98.16 | 0.89 | 98.07 | -0.09 | |
| HJ-2507-F7054 | Selank | 24 Jul 2025 | 2025-Q3 | 5 | 99.30 | 0.50 | 99.40 | +0.10 | |
| HJ-2507-Y6433 | Semaglutide | 23 Jul 2025 | 2025-Q3 | 9 | 98.39 | 1.09 | 98.77 | +0.38 | |
| HJ-2507-P6133 | L-Glutathione (reduced) | 20 Jul 2025 | 2025-Q4 | 1 | 98.73 | n<2 | 99.33 | +0.60 | |
| HJ-2507-E6156 | Semaglutide | 10 Jul 2025 | 2025-Q3 | 7 | 99.74 | 0.35 | 99.24 | -0.50 | |
| HJ-2507-V6231 | Epitalon | 09 Jul 2025 | 2025-Q4 | 5 | 99.10 | 0.40 | 99.07 | -0.03 | |
| HJ-2505-H6642 | Tirzepatide | 30 May 2025 | 2025-Q2 | 13 | 98.55 | 0.94 | 99.42 | +0.87 | |
| HJ-2504-X6056 | Ipamorelin | 23 Apr 2025 | 2025-Q3 | 9 | 99.60 | 0.77 | 99.69 | +0.09 | |
| HJ-2504-Y7274 | Semaglutide | 18 Apr 2025 | 2025-Q2 | 3 | 98.67 | 0.30 | 98.42 | -0.25 | |
| HJ-2503-M6961 | GHK-Cu | 24 Mar 2025 | 2025-Q3 | 1 | 99.08 | n<2 | 99.50 | +0.42 | |
| HJ-2503-M6159 | BPC-157 | 08 Mar 2025 | 2025-Q3 | 3 | 99.93 | 0.00 | 100.00 | +0.07 | |
| HJ-2502-P6662 | Tirzepatide | 13 Feb 2025 | 2025-Q1 | 3 | 99.59 | 0.64 | 99.74 | +0.15 | |
| HJ-2502-E7144 | AOD-9604 | 12 Feb 2025 | 2025-Q1 | 8 | 98.61 | 0.54 | 99.14 | +0.53 | |
| HJ-2502-U5979 | TB-500 | 11 Feb 2025 | 2025-Q3 | 1 | 99.74 | n<2 | 99.38 | -0.36 | |
| HJ-2501-G5680 | MK-677 (Ibutamoren mesylate) | 24 Jan 2025 | 2025-Q2 | 9 | 99.73 | 0.77 | 99.77 | +0.04 | |
| HJ-2501-P5963 | Tirzepatide | 21 Jan 2025 | 2025-Q1 | 14 | 98.52 | 1.38 | 98.58 | +0.06 | |
| HJ-2501-M6535 | Selank | 19 Jan 2025 | 2025-Q1 | 2 | 99.40 | 0.21 | 99.26 | -0.14 | |
| HJ-2501-A6454 | TB-500 | 02 Jan 2025 | 2025-Q1 | 8 | 99.58 | 0.52 | 99.50 | -0.08 | |
| HJ-2412-C6855 | Retatrutide | 05 Dec 2024 | 2025-Q2 | 8 | 97.82 | 1.10 | 97.81 | -0.01 | |
| HJ-2411-M5834 | Retatrutide | 20 Nov 2024 | 2024-Q4 | 8 | 98.37 | 1.33 | 98.27 | -0.10 | |
| HJ-2410-G5632 | IGF-1 LR3 | 01 Oct 2024 | 2025-Q1 | 2 | 98.26 | 0.05 | 99.90 | +1.64 | |
| HJ-2402-M6198 | BPC-157 | 29 Feb 2024 | 2024-Q2 | 14 | 99.54 | 0.80 | 99.82 | +0.28 |